Angiologix Inc.

Ann Arbor’s Everist Genomics Buys Angiologix Inc.

Everest Genomics announced Monday it has completed the acquisition of 100 percent of the shares of Mountain View, Calif.-based Angiologix Inc., developer of the AngioDefender device for diagnosing heart and vein disease.

WWJ Newsradio 950–10/31/2011

Follow

Get every new post delivered to your Inbox.

Join 2,631 other followers